$1.33
0.010.76%
At Close: -
$1.38
0.053.77%
After Hours: 7:46 PM EDT
15 minutes delayed
Comments
Loading...
Aclaris Therapeutics
ACRSNASDAQ
Aclaris Therapeutics (NASDAQ:ACRS) Stock, Insider Trading Activity
Aclaris Therapeutics: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Aclaris Therapeutics Inc Insiders Doing?
At Aclaris Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of 2.05M shares for a total value of $2.35M.
Notable Recent Insider Buys and Sales
- On June 13, 2024, Braden Michael Leonard, the company's - purchased 1.61M shares for $1.11 each.
- On July 1, 2024, Braden Michael Leonard, the company's - purchased 1.54M shares for $1.13 each.
- On June 18, 2024, Braden Michael Leonard, the company's - purchased 545K shares for $1.15 each.
Ownership Statistics for Aclaris Therapeutics Inc
Institutional Shares Held
15.382M
Institutional Percentage Held
21.6%
| Jul 22, 2024 | Braden Michael Leonard | — | 154.72K | $1.30 | $201.81K | BUY | 1.15% | 13.60M | Jul 18 - Jul 22 | View |
| Jul 05, 2024 | Braden Michael Leonard | — | 352.40K | $1.15 | $405.89K | BUY | 2.69% | 13.45M | Jul 02 - Jul 05 | View |
| Jul 01, 2024 | Braden Michael Leonard | — | 1.54M | $1.13 | $1.74M | BUY | 13.36% | 13.10M | Jun 27 - Jul 01 | View |
| Jun 18, 2024 | Braden Michael Leonard | — | 545.00K | $1.15 | $628.21K | BUY | 4.95% | 11.55M | Jun 14 - Jun 18 | View |
| Jun 13, 2024 | Braden Michael Leonard | — | 1.61M | $1.11 | $1.78M | BUY | 17.15% | 11.01M | Jun 11 - Jun 13 | View |
| Mar 05, 2024 | William Kenneth Andrew Powell | DIRECTOR | 14.50K | $1.24 | $17.95K | BUY | 100.95% | 28.86K | Mar 01 - Mar 04 | View |
| Oct 25, 2023 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | -6.00K | $5.08 | -$30.46K | SELL | -4.41% | 129.92K | Oct 23 | View |
| Sep 07, 2023 | Kevin Balthaser | CHIEF FINANCIAL OFFICER | 9.49K | $7.90 | $74.97K | BUY | 158.93% | 15.46K | Sep 06 | View |
| Aug 28, 2023 | James Loerop | CHIEF BUSINESS OFFICER | 14.71K | $6.80 | $99.96K | BUY | 210.58% | 21.69K | Aug 28 | View |
| Aug 22, 2023 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | -6.00K | $7.32 | -$43.89K | SELL | -4.23% | 135.92K | Aug 21 | View |
| Jun 22, 2023 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | -6.00K | $10.28 | -$61.66K | SELL | -4.06% | 141.92K | Jun 20 | View |
| Mar 17, 2023 | Douglas Manion | PRES AND CEO | 6.30K | $7.86 | $49.53K | BUY | 96.92% | 12.80K | Mar 17 | View |
| Mar 09, 2023 | Douglas Manion | PRES AND CEO | 6.50K | $7.74 | $50.28K | BUY | ∞ | 6.50K | Mar 09 | View |
| Mar 03, 2023 | Neal Walker | DIRECTOR | 97.44K | $12.50 | -$740.66K | SELL-OPTIONS | 8.29% | 1.27M | Mar 01 - Mar 03 | View |
| Mar 03, 2023 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | 56.34K | $12.51 | -$385.64K | SELL-OPTIONS | 61.52% | 147.92K | Mar 01 - Mar 03 | View |
| Mar 03, 2023 | Kevin Balthaser | CHIEF FINANCIAL OFFICER | 4.56K | $12.45 | -$23.58K | SELL-OPTIONS | 650.86% | 5.26K | Mar 01 - Mar 03 | View |
| Feb 17, 2023 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | -5.00K | $13.06 | -$65.31K | SELL | -5.18% | 91.58K | Feb 15 | View |
| Feb 10, 2023 | James Loerop | CHIEF BUSINESS OFFICER | -4.27K | $13.89 | -$59.27K | SELL | -37.93% | 6.98K | Feb 08 | View |
| Feb 03, 2023 | Neal Walker | DIRECTOR | -30.00K | $16.66 | -$499.92K | SELL | -2.49% | 1.18M | Feb 01 - Feb 02 | View |
| Jan 04, 2023 | Neal Walker | DIRECTOR | -40.00K | $15.11 | -$604.56K | SELL | -3.21% | 1.21M | Jan 03 - Jan 04 | View |
| Dec 16, 2022 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | -5.00K | $15.88 | -$79.41K | SELL | -4.92% | 96.58K | Dec 15 | View |
| Nov 14, 2022 | ANDREW SCHIFF | DIRECTOR | -53.93K | $17.05 | -$919.59K | SELL | -11.04% | 434.45K | Nov 10 - Nov 14 | View |
| Oct 26, 2022 | ANDREW SCHIFF | DIRECTOR | -41.17K | $17.01 | -$700.36K | SELL | -7.78% | 488.38K | Oct 24 - Oct 26 | View |
| Oct 19, 2022 | ANDREW SCHIFF | DIRECTOR | -52.04K | $16.57 | -$862.11K | SELL | -8.95% | 529.55K | Oct 17 - Oct 18 | View |
| Oct 19, 2022 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | -5.00K | $15.98 | -$79.91K | SELL | -4.69% | 101.58K | Oct 17 | View |
| Oct 11, 2022 | ANDREW SCHIFF | DIRECTOR | -7.32K | $16.16 | -$118.35K | SELL | -1.24% | 581.59K | Oct 07 | View |
| Oct 06, 2022 | ANDREW SCHIFF | DIRECTOR | -45.54K | $16.45 | -$749.00K | SELL | -7.18% | 588.92K | Oct 04 - Oct 06 | View |
| Jun 21, 2022 | ANDREW SCHIFF | DIRECTOR | -19.57K | $15.14 | -$296.27K | SELL | -2.99% | 634.46K | Jun 17 | View |
| Apr 25, 2022 | Neal Walker | PRESIDENT AND CEO | -70.00K | $15.15 | -$1.06M | SELL | -5.32% | 1.25M | Apr 21 - Apr 25 | View |
| Apr 20, 2022 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | -30.00K | $16.28 | -$488.30K | SELL | -21.97% | 106.58K | Apr 18 | View |
| Mar 14, 2022 | Neal Walker | PRESIDENT AND CEO | -56.30K | $15.91 | -$896.05K | SELL | -4.10% | 1.32M | Mar 11 | View |
| Mar 14, 2022 | Frank Ruffo | CHIEF FINANCIAL OFFICER | -12.82K | $15.55 | -$199.33K | SELL | -5.97% | 201.88K | Mar 10 | View |
| Mar 14, 2022 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | -27.16K | $15.71 | -$426.80K | SELL | -16.59% | 136.58K | Mar 10 | View |
| Feb 11, 2022 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | -383.00 | $12.68 | -$4.86K | SELL | -0.44% | 87.49K | Feb 09 | View |
| Feb 11, 2022 | Frank Ruffo | CHIEF FINANCIAL OFFICER | -1.39K | $12.66 | -$17.57K | SELL | -0.80% | 172.36K | Feb 09 | View |
| Feb 11, 2022 | Neal Walker | PRESIDENT AND CEO | -3.60K | $12.66 | -$45.51K | SELL | -0.29% | 1.24M | Feb 09 | View |
| Jul 14, 2021 | David Gordon | CHIEF MEDICAL OFFICER | -2.63K | $16.98 | -$44.67K | SELL | -1.75% | 147.45K | Jul 13 | View |
| Jun 04, 2021 | Kamil AliJackson | CHIEF LEGAL OFFICER | -9.49K | $21.96 | -$208.42K | SELL | -7.21% | 122.20K | Jun 03 | View |
| Jun 02, 2021 | David Gordon | CHIEF MEDICAL OFFICER | 35.59K | $22.01 | -$1.14M | SELL-OPTIONS | 32.80% | 144.08K | Jun 01 - Jun 02 | View |
| Jun 02, 2021 | Kamil AliJackson | CHIEF LEGAL OFFICER | -11.93K | $22.10 | -$996.96K | SELL | -8.31% | 131.69K | Jun 01 - Jun 02 | View |
| Jun 02, 2021 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | 28.21K | $21.64 | -$471.44K | SELL-OPTIONS | 49.21% | 85.53K | Jun 01 - Jun 02 | View |
| Jun 02, 2021 | Frank Ruffo | CHIEF FINANCIAL OFFICER | 18.15K | $21.64 | -$325.38K | SELL-OPTIONS | 11.96% | 169.87K | Jun 01 - Jun 02 | View |
| Jun 02, 2021 | Neal Walker | PRESIDENT AND CEO | 39.76K | $21.64 | -$719.73K | SELL-OPTIONS | 3.33% | 1.23M | Jun 01 - Jun 02 | View |
| May 07, 2021 | Kamil AliJackson | CHIEF LEGAL OFFICER | 0.00 | $17.06 | -$261.21K | SELL-OPTIONS | 0.00% | 143.62K | May 06 - May 07 | View |
| May 05, 2021 | Kamil AliJackson | CHIEF LEGAL OFFICER | 0.00 | $17.37 | -$604.02K | SELL-OPTIONS | 0.00% | 143.62K | May 03 - May 05 | View |
| Apr 26, 2021 | Frank Ruffo | CHIEF FINANCIAL OFFICER | -87.34K | $26.45 | -$2.31M | SELL | -36.53% | 151.72K | Apr 22 - Apr 26 | View |
| Apr 26, 2021 | Neal Walker | PRESIDENT AND CEO | -30.00K | $26.84 | -$805.24K | SELL | -2.45% | 1.19M | Apr 22 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.